RBA Wealth Management LLC Sells 379 Shares of MetLife, Inc. (NYSE:MET)

RBA Wealth Management LLC trimmed its position in MetLife, Inc. (NYSE:METFree Report) by 0.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 77,203 shares of the financial services provider’s stock after selling 379 shares during the quarter. MetLife accounts for approximately 2.4% of RBA Wealth Management LLC’s portfolio, making the stock its 9th largest holding. RBA Wealth Management LLC’s holdings in MetLife were worth $6,321,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of MET. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of MetLife by 1.5% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock worth $375,179,000 after purchasing an additional 68,579 shares during the period. Nordea Investment Management AB increased its holdings in MetLife by 16.8% during the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock valued at $347,735,000 after purchasing an additional 608,224 shares in the last quarter. Swedbank AB boosted its position in MetLife by 76.0% in the 4th quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock valued at $283,862,000 after buying an additional 1,496,645 shares during the last quarter. Jennison Associates LLC boosted its position in shares of MetLife by 3.6% in the 4th quarter. Jennison Associates LLC now owns 3,274,258 shares of the financial services provider’s stock worth $268,096,000 after purchasing an additional 114,166 shares during the last quarter. Finally, Stifel Financial Corp raised its stake in shares of MetLife by 5.0% in the 3rd quarter. Stifel Financial Corp now owns 2,239,841 shares of the financial services provider’s stock valued at $184,744,000 after purchasing an additional 105,762 shares during the period. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

MetLife Trading Down 1.2 %

Shares of NYSE MET opened at $85.48 on Tuesday. The business has a 50 day simple moving average of $84.06 and a 200 day simple moving average of $80.54. MetLife, Inc. has a 52 week low of $64.61 and a 52 week high of $89.05. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. The stock has a market cap of $59.18 billion, a price-to-earnings ratio of 17.23, a PEG ratio of 0.66 and a beta of 1.07.

MetLife Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be paid a $0.545 dividend. This represents a $2.18 annualized dividend and a yield of 2.55%. The ex-dividend date is Tuesday, February 4th. MetLife’s payout ratio is 43.95%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. TD Cowen boosted their price target on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. JPMorgan Chase & Co. increased their price objective on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Wells Fargo & Company reduced their price objective on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research note on Tuesday, January 14th. Barclays lifted their price objective on shares of MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, January 6th. Finally, BMO Capital Markets began coverage on shares of MetLife in a research note on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, MetLife presently has a consensus rating of “Moderate Buy” and a consensus target price of $90.46.

View Our Latest Analysis on MET

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.